Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 166,69k | Automatic Disposition | 41,67 | 77,39k | -4,91% |
| 2026-06-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 111,66k | Derivative Exercise and Sale | 19,34 - 41,67 | 77,39k | - |
| 2026-05-29 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -16,22k | 371,03k | Derivative Exercise and Sale | 19,34 - 42,36 | 7,72k | - |
| 2026-05-21 | Dr. Christopher I. WrightIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 27,68k | 20,28% |
| 2026-05-21 | Dr. Christopher I. WrightIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 27,68k | - |
| 2026-05-21 | Mr. Frank Anders WilsonLead Independent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 35,75k | 15,01% |
| 2026-05-21 | Mr. Frank Anders WilsonLead Independent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 35,75k | - |
| 2026-05-21 | Dr. Nancy L. SnydermanIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 36,18k | 14,81% |
| 2026-05-21 | Dr. Nancy L. SnydermanIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 36,18k | - |
| 2026-05-21 | Mr. Brian P. McKeonIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 48,54k | 10,64% |
| 2026-05-21 | Mr. Brian P. McKeonIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 48,54k | - |
| 2026-05-21 | Ms. Nancy S. LurkerIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 18,22k | 34,43% |
| 2026-05-21 | Ms. Nancy S. LurkerIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 18,22k | - |
| 2026-05-21 | Dr. Cato T. LaurencinIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 33,77k | 16,04% |
| 2026-05-21 | Dr. Cato T. LaurencinIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 33,77k | - |
| 2026-05-21 | Dr. Richard Brian GaynorIndependent Director | -1,48k | 54,50k | Derivative Exercise and Sale | 36,95 | 35,75k | - |
| 2026-05-21 | Dr. Richard Brian GaynorIndependent Director | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 35,75k | 15,01% |
| 2026-05-21 | Mr. Shane Martin CookeIndependent Director | 2,94k | 0,00 | Derivative Exercise and Retained Stock | - | 106,68k | 2,83% |
| 2026-05-21 | Mr. Shane Martin CookeIndependent Director | -3,21k | 118,50k | Derivative Exercise and Sale | 36,95 | 106,68k | - |
| 2026-05-04 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -2,03k | 67,53k | Automatic Disposition | 33,20 | 231,56k | -0,87% |
| 2026-05-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 70,28k | Derivative Exercise and Sale | 19,34 - 33,40 | 81,39k | - |
| 2026-05-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 133,58k | Automatic Disposition | 33,40 | 81,39k | -4,68% |
| 2026-04-11 | Ms. Nancy S. LurkerIndependent Director | 2,85k | 0,00 | Derivative Exercise and Retained Stock | - | 13,56k | 26,62% |
| 2026-04-11 | Ms. Nancy S. LurkerIndependent Director | -901,00 | 30,06k | Derivative Exercise and Sale | 33,36 | 13,56k | - |
| 2026-04-06 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -2,03k | 70,32k | Automatic Disposition | 34,57 | 233,59k | -0,86% |
| 2026-04-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 80,86k | Derivative Exercise and Sale | 19,34 - 35,51 | 85,39k | - |
| 2026-04-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 142,05k | Automatic Disposition | 35,51 | 85,39k | -4,47% |
| 2026-03-02 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -6,89k | 201,81k | Automatic Disposition | 29,29 | 7,72k | -47,17% |
| 2026-03-02 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6,00k | 180,00k | Automatic Disposition | 30,00 | 109,77k | -5,18% |
| 2026-03-02 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -4,07k | 120,11k | Automatic Disposition | 29,29 - 29,76 | 235,63k | -1,70% |
| 2026-03-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 51,90k | Derivative Exercise and Sale | 19,34 - 29,72 | 89,39k | - |
| 2026-03-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 118,88k | Automatic Disposition | 29,72 | 89,39k | -4,28% |
| 2026-02-26 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 1,94k | 0,00 | Derivative Exercise and Retained Stock | - | 14,61k | 15,31% |
| 2026-02-26 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -808,00 | 24,83k | Derivative Exercise and Sale | 30,73 | 14,61k | - |
| 2026-02-26 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 115,77k | 2,67% |
| 2026-02-26 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -2,40k | 73,84k | Derivative Exercise and Sale | 30,73 | 115,77k | - |
| 2026-02-26 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 4,63k | 0,00 | Derivative Exercise and Retained Stock | - | 241,31k | 1,95% |
| 2026-02-26 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -3,70k | 113,55k | Derivative Exercise and Sale | 30,73 | 241,31k | - |
| 2026-02-26 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 3,82k | 0,00 | Derivative Exercise and Retained Stock | - | 93,39k | 4,26% |
| 2026-02-26 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3,05k | 93,70k | Derivative Exercise and Sale | 30,73 | 93,39k | - |
| 2026-02-26 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 3,82k | 0,00 | Derivative Exercise and Retained Stock | - | 239,69k | 1,62% |
| 2026-02-26 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -3,05k | 93,70k | Derivative Exercise and Sale | 30,73 | 239,69k | - |
| 2026-02-23 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 12,67k | 14,57% |
| 2026-02-23 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -672,00 | 21,63k | Derivative Exercise and Sale | 32,19 | 12,67k | - |
| 2026-02-23 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 112,76k | 3,26% |
| 2026-02-23 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -2,85k | 91,58k | Derivative Exercise and Sale | 32,19 | 112,76k | - |
| 2026-02-23 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 4,86k | 0,00 | Derivative Exercise and Retained Stock | - | 236,68k | 2,10% |
| 2026-02-23 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -3,88k | 124,90k | Derivative Exercise and Sale | 32,19 | 236,68k | - |
| 2026-02-23 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 4,28k | 0,00 | Derivative Exercise and Retained Stock | - | 89,57k | 5,01% |
| 2026-02-23 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3,41k | 109,90k | Derivative Exercise and Sale | 32,19 | 89,57k | - |
| 2026-02-23 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 4,28k | 0,00 | Derivative Exercise and Retained Stock | - | 235,88k | 1,85% |
| 2026-02-23 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -3,41k | 109,90k | Derivative Exercise and Sale | 32,19 | 235,88k | - |
| 2026-02-18 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | 3,34k | 0,00 | Derivative Exercise and Retained Stock | - | 11,06k | 43,28% |
| 2026-02-18 | Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance | -1,69k | 53,93k | Derivative Exercise and Sale | 32,00 - 32,02 | 11,06k | - |
| 2026-02-18 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | 8,25k | 0,00 | Derivative Exercise and Retained Stock | - | 109,20k | 8,18% |
| 2026-02-18 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -4,15k | 132,71k | Derivative Exercise and Sale | 32,00 - 32,02 | 109,20k | - |
| 2026-02-18 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | 9,66k | 0,00 | Derivative Exercise and Retained Stock | - | 85,30k | 12,77% |
| 2026-02-18 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -6,91k | 221,22k | Derivative Exercise and Sale | 32,00 - 32,02 | 85,30k | - |
| 2026-02-18 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | 10,27k | 0,00 | Derivative Exercise and Retained Stock | - | 231,82k | 4,64% |
| 2026-02-18 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -7,93k | 253,71k | Derivative Exercise and Sale | 32,00 - 32,02 | 231,82k | - |
| 2026-02-18 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 8,50k | 0,00 | Derivative Exercise and Retained Stock | - | 231,60k | 3,81% |
| 2026-02-18 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -5,53k | 177,10k | Derivative Exercise and Sale | 32,00 - 32,02 | 231,60k | - |
| 2026-02-05 | Mr. Richard F. PopsChairman & CEO | -62,23k | 2,09M | Sale to Issuer | 33,55 | 1,38M | -4,32% |
| 2026-02-05 | Mr. Blair C. JacksonExec. VP, Chief Risk Officer & COO | -8,63k | 289,40k | Sale to Issuer | 33,55 | 221,55k | -3,75% |
| 2026-02-05 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6,39k | 214,35k | Sale to Issuer | 33,55 | 100,95k | -5,95% |
| 2026-02-05 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -7,45k | 250,08k | Sale to Issuer | 33,55 | 75,64k | -8,97% |
| 2026-02-05 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -7,62k | 255,62k | Sale to Issuer | 33,55 | 223,11k | -3,30% |
| 2026-02-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 74,52k | Derivative Exercise and Sale | 19,34 - 34,24 | 57,74k | - |
| 2026-02-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 134,16k | Automatic Disposition | 33,54 | 57,74k | -6,48% |
| 2026-02-02 | Mr. Shane Martin CookeIndependent Director | -61,20k | 179,30k | Derivative Exercise and Sale | 31,64 - 34,78 | 103,74k | - |
| 2026-01-08 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 53,31k | Derivative Exercise and Sale | 19,34 - 30,00 | 61,74k | - |
| 2026-01-02 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 112,00k | Automatic Disposition | 28,00 | 61,74k | -6,08% |
| 2025-12-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -3,75k | 39,96k | Derivative Exercise and Sale | 19,34 - 30,00 | 65,74k | - |
| 2025-12-01 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 117,20k | Automatic Disposition | 29,30 | 65,74k | -5,74% |
| 2025-11-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 55,21k | Derivative Exercise and Sale | 19,34 - 30,38 | 69,74k | - |
| 2025-11-03 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 121,53k | Automatic Disposition | 30,38 | 69,74k | -5,42% |
| 2025-10-15 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -5,00k | 60,95k | Derivative Exercise and Sale | 19,34 - 31,53 | 73,74k | - |
| 2025-10-15 | Dr. Craig C. HopkinsonExec. VP of Research & Development and Chief Medical Officer | -4,00k | 126,12k | Automatic Disposition | 31,53 | 73,74k | -5,15% |
| 2025-08-03 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | 1,12k | 0,00 | Derivative Exercise and Retained Stock | - | 205,37k | 0,55% |
| 2025-08-03 | Mr. David Joseph GaffinExec. VP, Chief Legal Officer, CCO & Secretary | -895,00 | 23,76k | Derivative Exercise and Sale | 26,55 | 205,37k | - |
| 2025-06-09 | Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer | -6,67k | 210,14k | Automatic Disposition | 31,09 - 31,95 | 86,21k | -7,18% |
| 2025-06-08 | Dr. Christopher I. WrightIndependent Director | 2,51k | 0,00 | Derivative Exercise and Retained Stock | - | 23,01k | 12,23% |
| 2025-06-08 | Dr. Christopher I. WrightIndependent Director | -793,00 | 25,15k | Derivative Exercise and Sale | 31,71 | 23,01k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
